Stay updated with breaking news from Adpt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) had its target price boosted by analysts at Piper Sandler from $14.00 to $15.00 in a note issued to investors on Monday, The Fly reports. Piper Sandler’s price objective suggests a potential upside of 134.38% from the stock’s current price. ADPT has been the subject of a number of […]
Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) posted its quarterly earnings results on Wednesday. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.06), Briefing.com reports. Adaptive Biotechnologies had a negative return on equity of 39.82% and a negative net margin of 105.87%. The business had revenue […]
Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) released its earnings results on Wednesday. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.06), Briefing.com reports. The firm had revenue of $37.65 million during the quarter, compared to analyst estimates of $36.81 million. Adaptive Biotechnologies had a negative return […]
The case against cutting healthcare spending
Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 6,120,000 shares, an increase of 14.8% from the March 15th total of 5,330,000 shares. Based on an average daily volume of 952,800 shares, the days-to-cover ratio is […]